Smilagenin Protects Dopaminergic Neurons in Chronic MPTP/Probenecid-Lesioned Parkinson's Disease Models.

Front Cell Neurosci · 2019 · PMC6371654 · PMID 30804756

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantP < 0.001actually significant

We found SMI treatment elevated the level of CREB phosphorylation and the differences between SMI at dose of 26 mg/kg/day and MPTP control was highly significant ( P < 0.001; Figure 8B ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.